SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '6bhu'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1N13_B_AG2B7011_1 (PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE ALPHA CHAIN PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE BETA CHAIN)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	ARG A1327 LEU A 753 ASP A 749 LEU A 746	None	1.17A	1n13B-6bhuA: undetectable 1n13C-6bhuA: undetectable	1n13B-6bhuA: 0.88 1n13C-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PTH_A_SALA710_1 (PROSTAGLANDIN H2 SYNTHASE-1)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 7	VAL A 711 VAL A 810 LEU A 816 ALA A 779 LEU A 778	None	1.35A	1pthA-6bhuA: undetectable	1pthA-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PTH_B_SALB711_1 (PROSTAGLANDIN H2 SYNTHASE-1)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 7	VAL A 711 VAL A 810 LEU A 816 ALA A 779 LEU A 778	None	1.35A	1pthB-6bhuA: undetectable	1pthB-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UTD_Q_TRPQ81_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 10	GLY A 803 HIS A 801 ALA A 745 THR A1328 ILE A 806	None None None ATP A1602 (-3.9A) None	1.27A	1utdQ-6bhuA: undetectable 1utdR-6bhuA: undetectable	1utdQ-6bhuA: undetectable 1utdR-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YA3_A_STRA1001_2 (MINERALOCORTICOID RECEPTOR)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 4	LEU A 455 LEU A 588 SER A 585 LEU A 462	None	1.10A	1ya3A-6bhuA: undetectable	1ya3A-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YA3_A_STRA1001_2 (MINERALOCORTICOID RECEPTOR)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 4	LEU A1436 LEU A1443 SER A1401 LEU A1387	None	1.11A	1ya3A-6bhuA: undetectable	1ya3A-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F8D_A_BEZA1002_0 (HTH-TYPE TRANSCRIPTIONAL REGULATOR BENM)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 10	LEU A1299 GLY A1298 LEU A1307 LEU A1309 ARG A1300	None	1.05A	2f8dA-6bhuA: undetectable	2f8dA-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F8L_A_SAMA400_1 (HYPOTHETICAL PROTEIN LMO1582)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 4	THR A1489 THR A1482 ASP A1453 ASP A1375	None None MG A1604 ( 4.1A) None	1.30A	2f8lA-6bhuA: undetectable	2f8lA-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OA1_B_ADNB2005_1 (TRYPTOPHAN HALOGENASE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 7	GLY A1425 GLY A1426 VAL A 420 SER A1380	None	0.76A	2oa1B-6bhuA: undetectable	2oa1B-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OKC_A_SAMA500_1 (TYPE I RESTRICTION ENZYME STYSJI M PROTEIN)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 6	THR A1489 THR A1482 ASP A1453 ASP A1375	None None MG A1604 ( 4.1A) None	1.28A	2okcA-6bhuA: undetectable	2okcA-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V57_A_PRLA1188_0 (TETR FAMILY TRANSCRIPTIONAL REPRESSOR LFRR)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 8	SER A1267 ASN A1054 ASP A1050 ARG A1046	None	0.96A	2v57A-6bhuA: 1.0	2v57A-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V57_C_PRLC1187_0 (TETR FAMILY TRANSCRIPTIONAL REPRESSOR LFRR)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 8	SER A1267 ASN A1054 ASP A1050 ARG A1046	None	0.96A	2v57C-6bhuA: 1.0	2v57C-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W3A_B_TOPB1189_1 (DIHYDROFOLATE REDUCTASE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 10	ILE A1471 ALA A1455 THR A1370 ILE A1449 THR A1456	None	1.20A	2w3aB-6bhuA: undetectable	2w3aB-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FI0_R_TRPR1001_0 (TRYPTOPHANYL-TRNA SYNTHETASE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 9	GLY A 401 VAL A 254 ASP A1178 VAL A1150 GLN A1185	None	1.47A	3fi0R-6bhuA: undetectable	3fi0R-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_C_ROFC903_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	3 / 3	SER A1177 GLN A1176 PHE A1173	None	0.76A	3g4lC-6bhuA: undetectable	3g4lC-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HJO_A_EAAA211_1 (GLUTATHIONE S-TRANSFERASE P)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 8	VAL A 258 TRP A 261 ILE A 423 GLY A 401	None	0.91A	3hjoA-6bhuA: undetectable	3hjoA-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M0W_E_P77E203_1 (PROTEIN S100-A4)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 8	ASP A1080 SER A 612 LEU A 437 ASP A 436	None	0.83A	3m0wE-6bhuA: 0.6 3m0wF-6bhuA: undetectable 3m0wG-6bhuA: 0.0 3m0wH-6bhuA: undetectable	3m0wE-6bhuA: 0.00 3m0wF-6bhuA: 0.00 3m0wG-6bhuA: 0.00 3m0wH-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M7R_A_VDXA425_1 (VITAMIN D3 RECEPTOR)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 12	VAL A 429 SER A 428 VAL A 611 GLN A 491 HIS A 494	None	1.07A	3m7rA-6bhuA: undetectable	3m7rA-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NBQ_B_URFB400_1 (URIDINE PHOSPHORYLASE 1)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 8	THR A 826 GLN A 774 LEU A 824 ILE A 811	None	0.81A	3nbqB-6bhuA: undetectable	3nbqB-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NBQ_C_URFC400_1 (URIDINE PHOSPHORYLASE 1)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 8	THR A 826 GLN A 774 LEU A 824 ILE A 811	None	0.75A	3nbqC-6bhuA: undetectable	3nbqC-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PRS_A_RITA1001_1 (ENDOTHIAPEPSIN)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 10	ILE A1504 ILE A1449 LEU A1481 THR A1447 ILE A1342	None	1.19A	3prsA-6bhuA: undetectable	3prsA-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UFG_B_LEUB289_0 (GLYCYL-TRNA SYNTHETASE ALPHA SUBUNIT)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	3 / 3	PHE A 558 SER A 991 SER A 988	None	0.86A	3ufgB-6bhuA: undetectable	3ufgB-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UY4_A_PAUA302_0 (PANTOTHENATE SYNTHETASE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 8	VAL A1431 ASP A 793 GLN A 713 ARG A1486	ATP A1601 ( 4.7A) None MG A1603 ( 2.3A) None	1.09A	3uy4A-6bhuA: undetectable	3uy4A-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A83_A_DXCA1160_0 (MAJOR POLLEN ALLERGEN BET V 1-A)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 12	PRO A 712 PRO A 794 LEU A 795 ILE A 811 ALA A 781	None	1.23A	4a83A-6bhuA: undetectable	4a83A-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ENH_A_FVXA602_1 (CHOLESTEROL 24-HYDROXYLASE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 12	LEU A1452 ILE A1372 ILE A1471 ALA A1455 THR A1456	None	0.97A	4enhA-6bhuA: undetectable	4enhA-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IAQ_A_2GMA2001_1 (CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 12	LEU A 746 ASP A 749 VAL A 776 LEU A 795 THR A1328	None None None None ATP A1602 (-3.9A)	1.40A	4iaqA-6bhuA: undetectable	4iaqA-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LRH_D_FOLD301_1 (FOLATE RECEPTOR ALPHA)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	3 / 3	HIS A 622 TRP A 261 SER A 417	None	0.71A	4lrhD-6bhuA: undetectable	4lrhD-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4M2X_A_TMQA202_1 (DIHYDROFOLATE REDUCTASE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 12	ILE A1467 ALA A1405 LEU A1450 LEU A1452 ILE A1471	None	0.99A	4m2xA-6bhuA: undetectable	4m2xA-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4M2X_C_TMQC202_1 (DIHYDROFOLATE REDUCTASE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 12	ILE A1467 ALA A1405 LEU A1450 LEU A1452 ILE A1471	None	0.94A	4m2xC-6bhuA: undetectable	4m2xC-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NPT_A_017A401_1 (PROTEASE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 9	GLY A1323 ILE A1483 THR A1479 ILE A1449 VAL A1292	None	1.04A	4nptA-6bhuA: undetectable	4nptA-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8F_B_BRLB501_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 6	ILE A 969 PHE A1042 GLY A1040 ILE A1090	CLR A1606 ( 4.7A) None None CLR A1606 ( 4.8A)	0.66A	4o8fB-6bhuA: 2.2	4o8fB-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8J_B_ADNB401_1 (RNA 3'-TERMINAL PHOSPHATE CYCLASE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 12	GLN A 491 ARG A 433 GLN A 608 PRO A1087 HIS A 494	None	1.47A	4o8jB-6bhuA: 0.6	4o8jB-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QTU_B_SAMB301_1 (PUTATIVE METHYLTRANSFERASE BUD23)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	GLN A 713 SER A1430 ASP A1460 ASP A1465	MG A1603 ( 2.3A) ATP A1601 (-2.9A) None None	1.46A	4qtuB-6bhuA: undetectable	4qtuB-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 10	ALA A1484 GLY A 771 GLY A 770 ASP A1453 SER A1333	None ATP A1602 (-4.0A) ATP A1602 (-4.2A) MG A1604 ( 4.1A) MG A1604 ( 1.9A)	1.05A	4qvmY-6bhuA: undetectable 4qvmZ-6bhuA: undetectable	4qvmY-6bhuA: 0.00 4qvmZ-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X5I_A_FOLA201_1 (DIHYDROFOLATE REDUCTASE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	3 / 3	ASP A 436 ARG A1248 ARG A1196	None	0.98A	4x5iA-6bhuA: undetectable	4x5iA-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DNU_A_BEZA319_0 (SHKAI2IB)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	HIS A1485 ILE A1490 ILE A1324 TYR A1493	ATP A1602 (-4.4A) None None None	1.17A	5dnuA-6bhuA: undetectable	5dnuA-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DNV_A_BEZA304_0 (SHKAI2IB)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	HIS A1485 ILE A1490 ILE A1324 TYR A1493	ATP A1602 (-4.4A) None None None	1.17A	5dnvA-6bhuA: undetectable	5dnvA-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5FHZ_C_REAC602_1 (ALDEHYDE DEHYDROGENASE FAMILY 1 MEMBER A3)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 10	ILE A 395 LEU A 257 GLN A 432 LEU A 616 LEU A 620	None	1.28A	5fhzC-6bhuA: undetectable	5fhzC-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G48_A_1FLA1375_1 (DNA POLYMERASE III SUBUNIT BETA)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 8	THR A 826 LEU A 824 ILE A 811 LEU A 791	None	0.91A	5g48A-6bhuA: undetectable	5g48A-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HM8_A_ADNA501_2 (ADENOSYLHOMOCYSTEINA SE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	GLU A1156 GLU A 760 THR A 759 LEU A 768	None	0.97A	5hm8A-6bhuA: undetectable	5hm8A-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HM8_B_ADNB501_2 (ADENOSYLHOMOCYSTEINA SE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	GLU A1156 GLU A 760 THR A 759 LEU A 768	None	0.96A	5hm8B-6bhuA: undetectable	5hm8B-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HM8_C_ADNC501_2 (ADENOSYLHOMOCYSTEINA SE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	GLU A1156 GLU A 760 THR A 759 LEU A 768	None	0.96A	5hm8C-6bhuA: undetectable	5hm8C-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HM8_D_ADND501_2 (ADENOSYLHOMOCYSTEINA SE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	GLU A1156 GLU A 760 THR A 759 LEU A 768	None	0.96A	5hm8D-6bhuA: undetectable	5hm8D-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HM8_E_ADNE501_2 (ADENOSYLHOMOCYSTEINA SE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	GLU A1156 GLU A 760 THR A 759 LEU A 768	None	0.96A	5hm8E-6bhuA: undetectable	5hm8E-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HM8_F_ADNF501_2 (ADENOSYLHOMOCYSTEINA SE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	GLU A1156 GLU A 760 THR A 759 LEU A 768	None	0.96A	5hm8F-6bhuA: undetectable	5hm8F-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HM8_G_ADNG501_2 (ADENOSYLHOMOCYSTEINA SE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	GLU A1156 GLU A 760 THR A 759 LEU A 768	None	0.86A	5hm8G-6bhuA: undetectable	5hm8G-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HM8_H_ADNH501_2 (ADENOSYLHOMOCYSTEINA SE)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	GLU A1156 GLU A 760 THR A 759 LEU A 768	None	0.96A	5hm8H-6bhuA: undetectable	5hm8H-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NNA_D_BZMD301_0 (ISATIN HYDROLASE A)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 12	ILE A 761 LEU A 768 SER A 755 ASP A 757 GLY A 756	None	1.22A	5nnaD-6bhuA: undetectable	5nnaD-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NWV_A_ACAA18_1 (SCRFP-TAG,GP41)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 12	GLY A 815 LYS A 814 ASN A 819 GLU A 670 LEU A 673	None	1.25A	5nwvA-6bhuA: undetectable	5nwvA-6bhuA: 1.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ODQ_A_ACTA703_0 (HETERODISULFIDE REDUCTASE, SUBUNIT A)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 6	ARG A 415 ALA A 414 PHE A 619 GLU A 422	None	1.26A	5odqA-6bhuA: undetectable	5odqA-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UBB_A_SAMA301_0 (ALPHA N-TERMINAL PROTEIN METHYLTRANSFERASE 1B)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 12	GLY A1508 VAL A1314 SER A1511 LEU A1513 VAL A1496	None	1.25A	5ubbA-6bhuA: undetectable	5ubbA-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_A_PCFA1808_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	LEU A1436 ALA A1440 LEU A1443 LEU A1387	None	0.83A	5vkqA-6bhuA: 6.2 5vkqD-6bhuA: 6.2	5vkqA-6bhuA: undetectable 5vkqD-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_B_PCFB1805_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	LEU A1387 LEU A1436 ALA A1440 LEU A1443	None	0.84A	5vkqA-6bhuA: 6.2 5vkqB-6bhuA: 6.2	5vkqA-6bhuA: undetectable 5vkqB-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_C_PCFC1806_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	LEU A1387 LEU A1436 ALA A1440 LEU A1443	None	0.80A	5vkqB-6bhuA: 6.2 5vkqC-6bhuA: 6.2	5vkqB-6bhuA: undetectable 5vkqC-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_D_PCFD1806_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 5	LEU A1387 LEU A1436 ALA A1440 LEU A1443	None	0.87A	5vkqC-6bhuA: 6.2 5vkqD-6bhuA: 6.2	5vkqC-6bhuA: undetectable 5vkqD-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_D_CVID301_1 (REGULATORY PROTEIN TETR)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 8	GLN A1008 GLY A1006 ILE A1003 TRP A 998	None	0.91A	5vlmD-6bhuA: undetectable	5vlmD-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XXI_A_LSNA503_1 (CYTOCHROME P450 2C9)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 12	ILE A1372 LEU A1404 GLN A1474 LEU A1452 PHE A1475	None	1.16A	5xxiA-6bhuA: undetectable	5xxiA-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BZO_C_FI8C1201_2 (DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA RNA POLYMERASE SIGMA FACTOR SIGA)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 4	LEU A 236 ASP A 240 GLN A 230 VAL A1200	None	1.49A	6bzoF-6bhuA: 4.2	6bzoF-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BZO_C_FI8C1201_2 (DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA RNA POLYMERASE SIGMA FACTOR SIGA)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 4	LEU A 236 ASP A 240 GLN A 230 VAL A1247	None	1.40A	6bzoF-6bhuA: 4.2	6bzoF-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CDU_G_EY4G502_0 (CHIMERIC ALPHA1GABAA RECEPTOR)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	4 / 8	ILE A1372 PRO A1376 ILE A1467 THR A1463	None	0.99A	6cduG-6bhuA: 4.1 6cduH-6bhuA: 1.8	6cduG-6bhuA: undetectable 6cduH-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM0_B_CYZB1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 10	LEU A 753 LEU A1305 ASP A1304 ILE A 761 GLY A 762	None	0.98A	6dm0B-6bhuA: undetectable 6dm0C-6bhuA: undetectable	6dm0B-6bhuA: 0.00 6dm0C-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWN_D_AQ4D602_0 (CYTOCHROME P450 1A1)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	5 / 12	ILE A 726 ASP A 757 ASP A 749 ILE A 761 LEU A 768	None	1.04A	6dwnD-6bhuA: undetectable	6dwnD-6bhuA: 0.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FGC_A_ACTA811_0 (GEPHYRIN)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	3 / 3	LEU A 824 LEU A 673 ARG A 822	None	0.66A	6fgcA-6bhuA: undetectable	6fgcA-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FGD_A_ACTA810_0 (GEPHYRIN)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	3 / 3	LEU A 824 LEU A 673 ARG A 822	None	0.67A	6fgdA-6bhuA: undetectable	6fgdA-6bhuA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GB9_A_ACTA508_0 (MOLYBDOPTERIN BIOSYNTHESIS PROTEIN CNX1)	6bhu	MULTIDRUG RESISTANCE-ASSOCIATE D PROTEIN 1 (Bos taurus)	3 / 3	VAL A1431 ALA A1458 GLN A 714	ATP A1601 ( 4.7A) None None	0.43A	6gb9A-6bhuA: undetectable	6gb9A-6bhuA: undetectable

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1N13_B_AG2B7011_1","PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE ALPHA CHAIN;PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE BETA CHAIN","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"ARG A1327;LEU A 753;ASP A 749;LEU A 746","None","1.17A","1n13B-6bhuA:undetectable;1n13C-6bhuA:undetectable","1n13B-6bhuA:0.88;1n13C-6bhuA:0.00"],["1PTH_A_SALA710_1","PROSTAGLANDIN H2 SYNTHASE-1","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"VAL A 711;VAL A 810;LEU A 816;ALA A 779;LEU A 778","None","1.35A","1pthA-6bhuA:undetectable","1pthA-6bhuA:0.00"],["1PTH_B_SALB711_1","PROSTAGLANDIN H2 SYNTHASE-1","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"VAL A 711;VAL A 810;LEU A 816;ALA A 779;LEU A 778","None","1.35A","1pthB-6bhuA:undetectable","1pthB-6bhuA:0.00"],["1UTD_Q_TRPQ81_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"GLY A 803;HIS A 801;ALA A 745;THR A1328;ILE A 806","None;None;None;ATP A1602 (-3.9A);None","1.27A","1utdQ-6bhuA:undetectable;1utdR-6bhuA:undetectable","1utdQ-6bhuA:undetectable;1utdR-6bhuA:undetectable"],["1YA3_A_STRA1001_2","MINERALOCORTICOID RECEPTOR","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"LEU A 455;LEU A 588;SER A 585;LEU A 462","None","1.10A","1ya3A-6bhuA:undetectable","1ya3A-6bhuA:0.00"],["1YA3_A_STRA1001_2","MINERALOCORTICOID RECEPTOR","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"LEU A1436;LEU A1443;SER A1401;LEU A1387","None","1.11A","1ya3A-6bhuA:undetectable","1ya3A-6bhuA:0.00"],["2F8D_A_BEZA1002_0","HTH-TYPE TRANSCRIPTIONAL REGULATOR BENM","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"LEU A1299;GLY A1298;LEU A1307;LEU A1309;ARG A1300","None","1.05A","2f8dA-6bhuA:undetectable","2f8dA-6bhuA:undetectable"],["2F8L_A_SAMA400_1","HYPOTHETICAL PROTEIN LMO1582","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"THR A1489;THR A1482;ASP A1453;ASP A1375","None;None; MG A1604 ( 4.1A);None","1.30A","2f8lA-6bhuA:undetectable","2f8lA-6bhuA:undetectable"],["2OA1_B_ADNB2005_1","TRYPTOPHAN HALOGENASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"GLY A1425;GLY A1426;VAL A 420;SER A1380","None","0.76A","2oa1B-6bhuA:undetectable","2oa1B-6bhuA:0.00"],["2OKC_A_SAMA500_1","TYPE I RESTRICTION ENZYME STYSJI M PROTEIN","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"THR A1489;THR A1482;ASP A1453;ASP A1375","None;None; MG A1604 ( 4.1A);None","1.28A","2okcA-6bhuA:undetectable","2okcA-6bhuA:undetectable"],["2V57_A_PRLA1188_0","TETR FAMILY TRANSCRIPTIONAL REPRESSOR LFRR","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"SER A1267;ASN A1054;ASP A1050;ARG A1046","None","0.96A","2v57A-6bhuA:1.0","2v57A-6bhuA:undetectable"],["2V57_C_PRLC1187_0","TETR FAMILY TRANSCRIPTIONAL REPRESSOR LFRR","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"SER A1267;ASN A1054;ASP A1050;ARG A1046","None","0.96A","2v57C-6bhuA:1.0","2v57C-6bhuA:undetectable"],["2W3A_B_TOPB1189_1","DIHYDROFOLATE REDUCTASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"ILE A1471;ALA A1455;THR A1370;ILE A1449;THR A1456","None","1.20A","2w3aB-6bhuA:undetectable","2w3aB-6bhuA:0.00"],["3FI0_R_TRPR1001_0","TRYPTOPHANYL-TRNA SYNTHETASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"GLY A 401;VAL A 254;ASP A1178;VAL A1150;GLN A1185","None","1.47A","3fi0R-6bhuA:undetectable","3fi0R-6bhuA:undetectable"],["3G4L_C_ROFC903_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",3,"SER A1177;GLN A1176;PHE A1173","None","0.76A","3g4lC-6bhuA:undetectable","3g4lC-6bhuA:undetectable"],["3HJO_A_EAAA211_1","GLUTATHIONE S-TRANSFERASE P","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"VAL A 258;TRP A 261;ILE A 423;GLY A 401","None","0.91A","3hjoA-6bhuA:undetectable","3hjoA-6bhuA:0.00"],["3M0W_E_P77E203_1","PROTEIN S100-A4;PROTEIN S100-A4;PROTEIN S100-A4;PROTEIN S100-A4","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"ASP A1080;SER A 612;LEU A 437;ASP A 436","None","0.83A","3m0wE-6bhuA:0.6;3m0wF-6bhuA:undetectable;3m0wG-6bhuA:0.0;3m0wH-6bhuA:undetectable","3m0wE-6bhuA:0.00;3m0wF-6bhuA:0.00;3m0wG-6bhuA:0.00;3m0wH-6bhuA:0.00"],["3M7R_A_VDXA425_1","VITAMIN D3 RECEPTOR","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"VAL A 429;SER A 428;VAL A 611;GLN A 491;HIS A 494","None","1.07A","3m7rA-6bhuA:undetectable","3m7rA-6bhuA:0.00"],["3NBQ_B_URFB400_1","URIDINE PHOSPHORYLASE 1","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"THR A 826;GLN A 774;LEU A 824;ILE A 811","None","0.81A","3nbqB-6bhuA:undetectable","3nbqB-6bhuA:0.00"],["3NBQ_C_URFC400_1","URIDINE PHOSPHORYLASE 1","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"THR A 826;GLN A 774;LEU A 824;ILE A 811","None","0.75A","3nbqC-6bhuA:undetectable","3nbqC-6bhuA:0.00"],["3PRS_A_RITA1001_1","ENDOTHIAPEPSIN","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"ILE A1504;ILE A1449;LEU A1481;THR A1447;ILE A1342","None","1.19A","3prsA-6bhuA:undetectable","3prsA-6bhuA:0.00"],["3UFG_B_LEUB289_0","GLYCYL-TRNA SYNTHETASE ALPHA SUBUNIT","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",3,"PHE A 558;SER A 991;SER A 988","None","0.86A","3ufgB-6bhuA:undetectable","3ufgB-6bhuA:undetectable"],["3UY4_A_PAUA302_0","PANTOTHENATE SYNTHETASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"VAL A1431;ASP A 793;GLN A 713;ARG A1486","ATP A1601 ( 4.7A);None; MG A1603 ( 2.3A);None","1.09A","3uy4A-6bhuA:undetectable","3uy4A-6bhuA:undetectable"],["4A83_A_DXCA1160_0","MAJOR POLLEN ALLERGEN BET V 1-A","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"PRO A 712;PRO A 794;LEU A 795;ILE A 811;ALA A 781","None","1.23A","4a83A-6bhuA:undetectable","4a83A-6bhuA:undetectable"],["4ENH_A_FVXA602_1","CHOLESTEROL 24-HYDROXYLASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"LEU A1452;ILE A1372;ILE A1471;ALA A1455;THR A1456","None","0.97A","4enhA-6bhuA:undetectable","4enhA-6bhuA:0.00"],["4IAQ_A_2GMA2001_1","CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"LEU A 746;ASP A 749;VAL A 776;LEU A 795;THR A1328","None;None;None;None;ATP A1602 (-3.9A)","1.40A","4iaqA-6bhuA:undetectable","4iaqA-6bhuA:0.00"],["4LRH_D_FOLD301_1","FOLATE RECEPTOR ALPHA","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",3,"HIS A 622;TRP A 261;SER A 417","None","0.71A","4lrhD-6bhuA:undetectable","4lrhD-6bhuA:undetectable"],["4M2X_A_TMQA202_1","DIHYDROFOLATE REDUCTASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"ILE A1467;ALA A1405;LEU A1450;LEU A1452;ILE A1471","None","0.99A","4m2xA-6bhuA:undetectable","4m2xA-6bhuA:0.00"],["4M2X_C_TMQC202_1","DIHYDROFOLATE REDUCTASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"ILE A1467;ALA A1405;LEU A1450;LEU A1452;ILE A1471","None","0.94A","4m2xC-6bhuA:undetectable","4m2xC-6bhuA:0.00"],["4NPT_A_017A401_1","PROTEASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"GLY A1323;ILE A1483;THR A1479;ILE A1449;VAL A1292","None","1.04A","4nptA-6bhuA:undetectable","4nptA-6bhuA:0.00"],["4O8F_B_BRLB501_2","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"ILE A 969;PHE A1042;GLY A1040;ILE A1090","CLR A1606 ( 4.7A);None;None;CLR A1606 ( 4.8A)","0.66A","4o8fB-6bhuA:2.2","4o8fB-6bhuA:0.00"],["4O8J_B_ADNB401_1","RNA 3'-TERMINAL PHOSPHATE CYCLASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"GLN A 491;ARG A 433;GLN A 608;PRO A1087;HIS A 494","None","1.47A","4o8jB-6bhuA:0.6","4o8jB-6bhuA:0.00"],["4QTU_B_SAMB301_1","PUTATIVE METHYLTRANSFERASE BUD23","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"GLN A 713;SER A1430;ASP A1460;ASP A1465"," MG A1603 ( 2.3A);ATP A1601 (-2.9A);None;None","1.46A","4qtuB-6bhuA:undetectable","4qtuB-6bhuA:undetectable"],["4QVM_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"ALA A1484;GLY A 771;GLY A 770;ASP A1453;SER A1333","None;ATP A1602 (-4.0A);ATP A1602 (-4.2A); MG A1604 ( 4.1A); MG A1604 ( 1.9A)","1.05A","4qvmY-6bhuA:undetectable;4qvmZ-6bhuA:undetectable","4qvmY-6bhuA:0.00;4qvmZ-6bhuA:0.00"],["4X5I_A_FOLA201_1","DIHYDROFOLATE REDUCTASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",3,"ASP A 436;ARG A1248;ARG A1196","None","0.98A","4x5iA-6bhuA:undetectable","4x5iA-6bhuA:undetectable"],["5DNU_A_BEZA319_0","SHKAI2IB","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"HIS A1485;ILE A1490;ILE A1324;TYR A1493","ATP A1602 (-4.4A);None;None;None","1.17A","5dnuA-6bhuA:undetectable","5dnuA-6bhuA:undetectable"],["5DNV_A_BEZA304_0","SHKAI2IB","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"HIS A1485;ILE A1490;ILE A1324;TYR A1493","ATP A1602 (-4.4A);None;None;None","1.17A","5dnvA-6bhuA:undetectable","5dnvA-6bhuA:undetectable"],["5FHZ_C_REAC602_1","ALDEHYDE DEHYDROGENASE FAMILY 1 MEMBER A3","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"ILE A 395;LEU A 257;GLN A 432;LEU A 616;LEU A 620","None","1.28A","5fhzC-6bhuA:undetectable","5fhzC-6bhuA:0.00"],["5G48_A_1FLA1375_1","DNA POLYMERASE III SUBUNIT BETA","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"THR A 826;LEU A 824;ILE A 811;LEU A 791","None","0.91A","5g48A-6bhuA:undetectable","5g48A-6bhuA:0.00"],["5HM8_A_ADNA501_2","ADENOSYLHOMOCYSTEINASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"GLU A1156;GLU A 760;THR A 759;LEU A 768","None","0.97A","5hm8A-6bhuA:undetectable","5hm8A-6bhuA:0.00"],["5HM8_B_ADNB501_2","ADENOSYLHOMOCYSTEINASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"GLU A1156;GLU A 760;THR A 759;LEU A 768","None","0.96A","5hm8B-6bhuA:undetectable","5hm8B-6bhuA:0.00"],["5HM8_C_ADNC501_2","ADENOSYLHOMOCYSTEINASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"GLU A1156;GLU A 760;THR A 759;LEU A 768","None","0.96A","5hm8C-6bhuA:undetectable","5hm8C-6bhuA:0.00"],["5HM8_D_ADND501_2","ADENOSYLHOMOCYSTEINASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"GLU A1156;GLU A 760;THR A 759;LEU A 768","None","0.96A","5hm8D-6bhuA:undetectable","5hm8D-6bhuA:0.00"],["5HM8_E_ADNE501_2","ADENOSYLHOMOCYSTEINASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"GLU A1156;GLU A 760;THR A 759;LEU A 768","None","0.96A","5hm8E-6bhuA:undetectable","5hm8E-6bhuA:0.00"],["5HM8_F_ADNF501_2","ADENOSYLHOMOCYSTEINASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"GLU A1156;GLU A 760;THR A 759;LEU A 768","None","0.96A","5hm8F-6bhuA:undetectable","5hm8F-6bhuA:0.00"],["5HM8_G_ADNG501_2","ADENOSYLHOMOCYSTEINASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"GLU A1156;GLU A 760;THR A 759;LEU A 768","None","0.86A","5hm8G-6bhuA:undetectable","5hm8G-6bhuA:0.00"],["5HM8_H_ADNH501_2","ADENOSYLHOMOCYSTEINASE","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"GLU A1156;GLU A 760;THR A 759;LEU A 768","None","0.96A","5hm8H-6bhuA:undetectable","5hm8H-6bhuA:0.00"],["5NNA_D_BZMD301_0","ISATIN HYDROLASE A","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"ILE A 761;LEU A 768;SER A 755;ASP A 757;GLY A 756","None","1.22A","5nnaD-6bhuA:undetectable","5nnaD-6bhuA:undetectable"],["5NWV_A_ACAA18_1","SCRFP-TAG,GP41","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"GLY A 815;LYS A 814;ASN A 819;GLU A 670;LEU A 673","None","1.25A","5nwvA-6bhuA:undetectable","5nwvA-6bhuA:1.25"],["5ODQ_A_ACTA703_0","HETERODISULFIDE REDUCTASE, SUBUNIT A","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"ARG A 415;ALA A 414;PHE A 619;GLU A 422","None","1.26A","5odqA-6bhuA:undetectable","5odqA-6bhuA:undetectable"],["5UBB_A_SAMA301_0","ALPHA N-TERMINAL PROTEIN METHYLTRANSFERASE 1B","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"GLY A1508;VAL A1314;SER A1511;LEU A1513;VAL A1496","None","1.25A","5ubbA-6bhuA:undetectable","5ubbA-6bhuA:undetectable"],["5VKQ_A_PCFA1808_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"LEU A1436;ALA A1440;LEU A1443;LEU A1387","None","0.83A","5vkqA-6bhuA:6.2;5vkqD-6bhuA:6.2","5vkqA-6bhuA:undetectable;5vkqD-6bhuA:undetectable"],["5VKQ_B_PCFB1805_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"LEU A1387;LEU A1436;ALA A1440;LEU A1443","None","0.84A","5vkqA-6bhuA:6.2;5vkqB-6bhuA:6.2","5vkqA-6bhuA:undetectable;5vkqB-6bhuA:undetectable"],["5VKQ_C_PCFC1806_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"LEU A1387;LEU A1436;ALA A1440;LEU A1443","None","0.80A","5vkqB-6bhuA:6.2;5vkqC-6bhuA:6.2","5vkqB-6bhuA:undetectable;5vkqC-6bhuA:undetectable"],["5VKQ_D_PCFD1806_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"LEU A1387;LEU A1436;ALA A1440;LEU A1443","None","0.87A","5vkqC-6bhuA:6.2;5vkqD-6bhuA:6.2","5vkqC-6bhuA:undetectable;5vkqD-6bhuA:undetectable"],["5VLM_D_CVID301_1","REGULATORY PROTEIN TETR","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"GLN A1008;GLY A1006;ILE A1003;TRP A 998","None","0.91A","5vlmD-6bhuA:undetectable","5vlmD-6bhuA:undetectable"],["5XXI_A_LSNA503_1","CYTOCHROME P450 2C9","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"ILE A1372;LEU A1404;GLN A1474;LEU A1452;PHE A1475","None","1.16A","5xxiA-6bhuA:undetectable","5xxiA-6bhuA:0.00"],["6BZO_C_FI8C1201_2","DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA;RNA POLYMERASE SIGMA FACTOR SIGA","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"LEU A 236;ASP A 240;GLN A 230;VAL A1200","None","1.49A","6bzoF-6bhuA:4.2","6bzoF-6bhuA:undetectable"],["6BZO_C_FI8C1201_2","DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA;RNA POLYMERASE SIGMA FACTOR SIGA","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"LEU A 236;ASP A 240;GLN A 230;VAL A1247","None","1.40A","6bzoF-6bhuA:4.2","6bzoF-6bhuA:undetectable"],["6CDU_G_EY4G502_0","CHIMERIC ALPHA1GABAA RECEPTOR","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",4,"ILE A1372;PRO A1376;ILE A1467;THR A1463","None","0.99A","6cduG-6bhuA:4.1;6cduH-6bhuA:1.8","6cduG-6bhuA:undetectable;6cduH-6bhuA:undetectable"],["6DM0_B_CYZB1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"LEU A 753;LEU A1305;ASP A1304;ILE A 761;GLY A 762","None","0.98A","6dm0B-6bhuA:undetectable;6dm0C-6bhuA:undetectable","6dm0B-6bhuA:0.00;6dm0C-6bhuA:0.00"],["6DWN_D_AQ4D602_0","CYTOCHROME P450 1A1","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",5,"ILE A 726;ASP A 757;ASP A 749;ILE A 761;LEU A 768","None","1.04A","6dwnD-6bhuA:undetectable","6dwnD-6bhuA:0.00"],["6FGC_A_ACTA811_0","GEPHYRIN","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",3,"LEU A 824;LEU A 673;ARG A 822","None","0.66A","6fgcA-6bhuA:undetectable","6fgcA-6bhuA:undetectable"],["6FGD_A_ACTA810_0","GEPHYRIN","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",3,"LEU A 824;LEU A 673;ARG A 822","None","0.67A","6fgdA-6bhuA:undetectable","6fgdA-6bhuA:undetectable"],["6GB9_A_ACTA508_0","MOLYBDOPTERIN BIOSYNTHESIS PROTEIN CNX1","6bhu","MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1","Bos taurus",3,"VAL A1431;ALA A1458;GLN A 714","ATP A1601 ( 4.7A);None;None","0.43A","6gb9A-6bhuA:undetectable","6gb9A-6bhuA:undetectable"]]